Evidence map›Paper›PMID 32299904›Full record

ArticleHaematologica2021

SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy.

Magdalena M Gerlach, Anna Stelling-Germani, Cheuk Ting Wu, Sebastian Newrzela, Claudia Döring, Visar Vela, Anne Müller, Sylvia Hartmann, Alexandar Tzankov

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Magdalena M GerlachInstitute of Medical Genetics and Pathology, University of Basel, Basel, Switzerland.
Anna Stelling-GermaniInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Cheuk Ting WuInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Sebastian NewrzelaInstitute of Pathology, Department of Pathology, Goethe University Frankfurt on Main, Germany.
Claudia DöringInstitute of Pathology, Department of Pathology, Goethe University Frankfurt on Main, Germany.
Visar VelaInstitute of Medical Genetics and Pathology, University of Basel, Basel, Switzerland.
Anne MüllerInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Sylvia HartmannInstitute of Pathology, Department of Pathology, Goethe University Frankfurt on Main, Germany.
Alexandar TzankovInstitute of Medical Genetics and Pathology, University of Basel, Basel, Switzerland.
Goethe University Frankfurt · DEUniversity of Basel · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hodgkin DiseaseDNA MethylationHumansPromoter Regions, GeneticSmad1 ProteinSmad1 ProteinSMAD1 protein, human

Identifiers

PMID32299904
PMCPMC7849564
OpenAlexW3016966613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.